Technical Outlook And Game Plan For Regeneron Pharmaceuticals, Inc (NASDAQ: REGN)
Regeneron Pharmaceuticals, Inc (REGN) concluded trading on Thursday at a closing price of $547.36, with 0.46 million shares of worth about $249.81 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -22.09% during that period and on July 03, 2025 the price saw a […]